ISSWSH Special Report on the US Food and Drug Administration Draft Guidance on Low Sexual Desire and Arousal: A New Hope or Old Habits Die Hard?

2017 ◽  
Vol 5 (2) ◽  
pp. 131-134 ◽  
Author(s):  
Noel N. Kim ◽  
Irwin Goldstein ◽  
James A. Simon ◽  
Murray A. Freedman ◽  
Sharon J. Parish
Keyword(s):  
Drug Administration ◽  
Sexual Desire ◽  
Food And Drug Administration ◽  
Draft Guidance ◽  
Special Report ◽  
Low Sexual Desire ◽  
The Us

Thoughts on the U.S. Food and Drug Administration (FDA) Draft Guidance on Low Sexual Desire and Arousal

2017 ◽  
Vol 5 (1) ◽  
pp. 1-2 ◽  
Author(s):  
Irwin Goldstein ◽  
William A. Fisher ◽  
Noel N. Kim ◽  
Sheryl A. Kingsberg ◽  
Anita H. Clayton ◽  
...  
Keyword(s):  
Drug Administration ◽  
Sexual Desire ◽  
Food And Drug Administration ◽  
Draft Guidance ◽  
Low Sexual Desire ◽  
The U.S

scholarly journals Implications of the US Food and Drug Administration draft guidance for mitigating septic reactions from platelet transfusions

2017 ◽  
Vol 1 (15) ◽  
pp. 1142-1147 ◽  
Author(s):  
Bruce S. Sachais ◽  
Sarai Paradiso ◽  
Donna Strauss ◽  
Beth H. Shaz
Keyword(s):  
Drug Administration ◽  
Food And Drug Administration ◽  
Draft Guidance ◽  
The Us ◽  
Platelet Transfusions

Cardiovascular and Renal Advisory Panel of the US Food and Drug Administration Considers Four Drugs

Circulation ◽  
1997 ◽  
Vol 95 (10) ◽  
pp. 2335-2335 ◽  
Author(s):  
Dan M. Roden
Keyword(s):  
Drug Administration ◽  
Food And Drug Administration ◽  
Advisory Panel ◽  
The Us

scholarly journals 2020 FDA TIDES (Peptides and Oligonucleotides) Harvest

2021 ◽  
Vol 14 (2) ◽  
pp. 145
Author(s):  
Othman Al Musaimi ◽  
Danah Al Shaer ◽  
Fernando Albericio ◽  
Beatriz de la Torre
Keyword(s):  
Adverse Effects ◽  
Global Health ◽  
Drug Administration ◽  
Mode Of Action ◽  
Chemical Structure ◽  
Food And Drug Administration ◽  
Health Crisis ◽  
New Drug ◽  
Target Mode ◽  
The Us

2020 has been an extremely difficult and challenging year as a result of the coronavirus disease 2019 (COVID-19) pandemic and one in which most efforts have been channeled into tackling the global health crisis. The US Food and Drug Administration (FDA) has approved 53 new drug entities, six of which fall in the peptides and oligonucleotides (TIDES) category. The number of authorizations for these kinds of drugs has been similar to that of previous years, thereby reflecting the consolidation of the TIDES market. Here, the TIDES approved in 2020 are analyzed in terms of chemical structure, medical target, mode of action, and adverse effects.

scholarly journals Aggregation and analysis of secondary pharmacology data from investigational new drug submissions at the US Food and Drug Administration

2021 ◽  
pp. 107098
Author(s):  
Andrew Dodson ◽  
Kevin Mi ◽  
Daniel P. Russo ◽  
Christina Scott ◽  
Muriel Saulnier ◽  
...  
Keyword(s):  
Drug Administration ◽  
Food And Drug Administration ◽  
New Drug ◽  
The Us
Sign in / Sign up

Export Citation Format

Share Document